Emperra successful with Series B financing
Emperra GmbH E-Health Technologies, a company that Portus assisted with closing its Series A financing three years ago, will receive further growth financing from Robert Bosch Venture Capital GmbH. Including the participation of the two managing partners, the investment amounts to US$ 3.1 Mio. The proceeds will be dedicated to product development and to support Emperra’s growth, especially in the U.S. and in Europe.
Emperra is a medical devices company that develops and distributes telemedical product systems under the brand Evesta for patients that suffer from Diabetes mellitus. The digital solutions ought to secure a fully automatic data collection and documentation, for blood sugar values and insulin units alike. With its medical devices, the start-up aims to provide better patient care and improve their quality of life. Besides, Emperra puts emphasis on mobile applications, using an app for smartphones. The application is thought to be combined with Bluetooth-ready blood glucose meters and sensors for continuous glucose measurement.